cochlioquinone a has been researched along with ritanserin in 1 studies
| Studies (cochlioquinone a) | Trials (cochlioquinone a) | Recent Studies (post-2010) (cochlioquinone a) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 735 | 75 | 71 |
| Protein | Taxonomy | cochlioquinone a (IC50) | ritanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldanzi, G; Bertoni, A; Capello, D; Fresu, LG; Gesu, A; Graziani, A; Massarotti, A; Ruffo, E; Snow, AL; Talmon, M; Tron, GC; Varma, KSS; Velnati, S | 1 |
1 other study(ies) available for cochlioquinone a and ritanserin
| Article | Year |
|---|---|
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Topics: Cell Death; Computer Simulation; Diacylglycerol Kinase; Drug Evaluation, Preclinical; Humans; Lymphoproliferative Disorders; Piperidines; Protein Kinase Inhibitors; Pyrimidinones; Quinazolinones; Ritanserin; Thiazoles | 2019 |